Dr Louise Collins Research group
Dr. Collins’s current research interests include investigating the mechanisms that regulate dopaminergic growth and survival and translating these findings to develop neuroprotective therapies that prevent dopaminergic (DA) neurodegeneration which is observed in diseases such as Parkinson’s disease (PD)
Find Out More